Some studies have found that emodin may inhibit NSCLC cell proliferation by downregulating the expressions of excision repair cross-complementary 1 (ERCC1) and DNA repair protein RAD51 homolog 1 (Rad51) with a dose-dependent pattern. Here, RAD51 is linked to non-small cell lung carcinoma.